hfbHealth, Food & BiotechnologyHealth, Food & Biotechnology2712-7648РОСБИОТЕХ10.36107/hfb.2019.i4.s252hfb-48Research ArticleЗДОРОВЬЕHEALTHЧесотка у детей. Проблема, требующая решенияChildren’s Scabies. Problem to be SolvedСоколоваТ. В.SokolovaT. V.

Соколова Татьяна Вениаминовна

125080, Москва, Волоколамское шоссе, дом 11

Tatiana V. Sokolova

11 Volokolamskoe highway, Moscow, 125080, Russian Federation

stv_morf2005@mail.ruМалярчукА. П.MalyarchukA. P.

Малярчук Александр Петрович

125080, Москва, Волоколамское шоссе, дом 11

Alеxandr P. Malyarchuk

11 Volokolamskoe highway, Moscow, 125080, Russian Federation

2236779@mail.ruФГБОУ ВО «Московский государственный университет пищевых производств»РоссияMoscow State University of Food ProductionRussian Federation201905052021141925Copyright © Соколова Т.В., Малярчук А.П., 20202020Соколова Т.В., Малярчук А.П.Sokolova T.V., Malyarchuk A.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.hfb-journal.ru/jour/article/view/48

В России с настоящее время отсутствуют препараты для лечения чесотки у детей грудного возраста. Создавшаяся в стране серьезная ситуация требует решения Министерством здравоохранения вопроса о возможности использования перметрина с этой целью. Единственный препарат, разрешенный ранее для лечения чесотки у детей до года (эсбиол + пиперонила бутоксид, спрегаль, Франция) не прошел повторную регистрацию в России, не вошел в Государственный реестр лекарственных средств и с 2014 года в страну не экспортируется. Анализ Кокрановских обзоров, зарубежных статей свидетельствует, что в Америке, Европе и Японии препаратом первой линии для лечения чесотки у детей является 5 % крем перметрина. Отечественным препаратом на его основе является 0,4 % водная эмульсия перметрина (медифокс). Авторами ранее доказана его высокая эффективность при лечении чесотки.

In Russia, there are currently no drugs for the treatment of infants’ scabies. The serious situation in the country requires the Ministry of Health to decide on the possibility of using permethrin for this purpose. The only drug previously approved for the treatment of scabies in children under one year old (esbiol + piperonyl butoxide, Spregal, France) has not been re-registered in Russia, has not been included in the State Register of Medicines and has not been exported to the country since 2014. An analysis of Cochrane reviews and foreign articles shows that in America, Europe and Japan, the first-line drug for treating scabies in children is 5 % permethrin cream. A domestic drug based on it is 0.4 % aqueous permethrin emulsion (medifox). The authors previously proved its high effectiveness in the treatment of scabies.

чесоткалечениеперметрингрудные детиscabiestreatmentpermethrininfantsReferencesМалярчук, А. П. (2006). Оптимизация диагностики, лечения и профилактике чесотки. [Малярчук, Александр Петрович. Автореф. дисс… канд. мед. наук. ГИУВ МО РФ]. Москва. Россия.Baker, C. J. (2013). Red Book atlas of pediatric infectious diseases. American Academy of Pediatrics.Малярчук, А. П. (2014). Влияние различных концентраций медифокса на эффективность лечения чесотки. Дерматология в России, 3(1).Currie, B. J., & McCarthy, J. S. (2010). Permethrin and ivermectin for scabies. New England Journal of Medicine, 362(8), 717-725.Олифер, В. В. (2006). Новые подходы к разработке скабицидных средств и совершенствование профилактических мероприятий в очагах чесотки. [ Олифер Вероника Валентиновна. Автореф.дисс…канд.биол.наук. ПМГМУ МЗ РФ]. Москва. Россия.Executive Committee of Guideline for the Diagnosis. (2017). Guideline for the diagnosis and treatment of scabies in Japan: Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Journal of Dermatology, 44(9), 991-1014.Рязанцев, И. В. (2004). Совершенствование лечебно- профилактических мероприятий при чесотке в ВС РФ. [Рязанцев, Иван Валерьевич. Автореф. дисс…канд.мед.наук. ГИУВ МО РФ]. Москва. Россия.Kazeminejad, A., & Ghahari, M. J.(2019) Scabies Treatment in Children: A Narrative Review. Journal Pediatrics Review, 7(2), 105-112.Соколова, Т. В., & Малярчук, А. П. (2009). Лечение чесотки. Клиническая дерматология и венерология, 6, 64-67.Mytton, O., Mcgready, R., Lee, S., Roberts, C., Ashley, E., Carrara, V., Thwai, K. L., Jay, M. P., Wiangambun, T., Singhasivanon, P., & Nosten, F. (2007). Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG an International Journal of Obstetrics & Gynaecology. BJOG An International Journal of Obstetrics & Gynaecology. http://doi.org/10.1111/j.1471-0528.2007.01290. xRosumeck, S., Nast, A., & Dressler, C. (2018). Ivermectin and permethrin for treating scabies. Cochrane Database of Systematic Reviews, (4). http://dx.doi.org/10.1002/14651858.CD012994Baker, C. J. (2013). Red Book atlas of pediatric infectious diseases. American Academy of Pediatrics.Salavastru, C. M., Chosidow, O., Boffa, M. J., Janier, M., & Tiplica, G. S. (2017). European guideline for the management of scabies. Journal of the European Academy of Dermatology and Venereology, 31(8), 1248-1253.Currie, B. J., & McCarthy, J. S. (2010). Permethrin and ivermectin for scabies. New England Journal of Medicine, 362(8), 717-725.Strong M., & Johnstone, P. (2011). Cochrane Review: Interventions for treating scabies. Evidence-Based Child Health: A Cochrane Review Journal, 6(6). https://doi.org/10.1002/ebch.861Executive Committee of Guideline for the Diagnosis. (2017). Guideline for the diagnosis and treatment of scabies in Japan: Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Journal of Dermatology, 44(9), 991-1014.Strong, M., & Johnstone, P. (2007). Interventions for treating scabies. Cochrane Database of Systematic Reviews, (3).Kazeminejad, A., & Ghahari, M. J.(2019) Scabies Treatment in Children: A Narrative Review. Journal Pediatrics Review, 7(2), 105-112.Strong, M., & Johnstone, P. (2010). Interventions for treating scabies (Review), The Cochrane Collaboration, 1-70.Mytton, O., Mcgready, R., Lee, S., Roberts, C., Ashley, E., Carrara, V., Thwai, K. L., Jay, M. P., Wiangambun, T., Singhasivanon, P., & Nosten, F. (2007). Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG an International Journal of Obstetrics & Gynaecology. BJOG An International Journal of Obstetrics & Gynaecology. http://doi.org/10.1111/j.1471-0528.2007.01290.xRosumeck, S., Nast, A., & Dressler, C. (2018). Ivermectin and permethrin for treating scabies. Cochrane Database of Systematic Reviews, (4). http://dx.doi.org/10.1002/14651858.CD012994Sunderkötter, C., Aebischer, A., Neufeld, M., Löser, C., Kreuter, A., Bialek, R., Hamm, H., & Feldmeier, H. (2019). Increase of scabies in Germany and development of resistant mites? Evidence and consequences. Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology], 17(1), 15–23. https://doi.org/10.1111/ddg.13706Salavastru, C. M., Chosidow, O., Boffa, M. J., Janier, M., & Tiplica, G. S. (2017). European guideline for the management of scabies. Journal of the European Academy of Dermatology and Venereology, 31(8), 1248-1253.Thadanipon, K., Anothaisintawee, T., Rattanasiri, S., Thakkinstian, A., & Attia, J. (2019). Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology, 80(5), 1435-1444.Strong M., & Johnstone, P. (2011). Cochrane Review: Interventions for treating scabies. Evidence-Based Child Health: A Cochrane Review Journal, 6(6). https://doi.org/10.1002/ebch.861Usha, V., & Nair, T. G. (2000). A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology, 42(2), 236-240.Strong, M., & Johnstone, P. (2007). Interventions for treating scabies. Cochrane Database of Systematic Reviews, (3).Van der Rhee, H. J., Farquhar, J. A., & Vermeulen, N. P. (1989). Efficacy and transdermal absorption of permethrin in scabies patients. Acta dermato-venereologica, 69(2), 170-176.Strong, M., & Johnstone, P. (2010). Interventions for treating scabies (Review), The Cochrane Collaboration, 1-70.Wendel, K., & Rompalo, A. (2002). Scabies and pediculosis pubis: an update of treatment regimens and general review. Clinical Infectious Diseases, 35(Supplement_2), S146-S151.Sunderkötter, C., Aebischer, A., Neufeld, M., Löser, C., Kreuter, A., Bialek, R., Hamm, H., & Feldmeier, H. (2019). Increase of scabies in Germany and development of resistant mites? Evidence and consequences. Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology], 17(1), 15–23. https://doi.org/10.1111/ddg.13706Workowski, K. A., Berman, S. (2010). Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbidity and Mortality Weekly Report, 59(12), 89–90.Thadanipon, K., Anothaisintawee, T., Rattanasiri, S., Thakkinstian, A., & Attia, J. (2019). Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology, 80(5), 1435-1444.Malyarchuk, A. P. (2006). Optimizaciya diagnostiki, lecheniya i profilaktike chesotki [Optimization of diagnosis, treatment and prevention of scabies] [Malyarchuk, Aleksandr Petrovich. Avtoref. diss… kand. med. nauk. GIUV MO RF]. Moskva. Rossiya.Usha, V., & Nair, T. G. (2000). A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology, 42(2), 236-240.Malyarchuk, A. P. (2014). The effect of various concentrations of medifox on the effectiveness of scabies treatment. Dermatologiya v Rossii [Dermatology in Russia], 3(1). URL: http://www.dermatology.ru/publications/derm.ross. 2014.01/31424/.Van der Rhee, H. J., Farquhar, J. A., & Vermeulen, N. P. (1989). Efficacy and transdermal absorption of permethrin in scabies patients. Acta dermato-venereologica, 69(2), 170-176.Olifer, V. V. (2006). Novye podhody k razrabotke skabicidnyh sredstv i sovershenstvovanie profilakticheskih meropriyatij v ochagah chesotki [New approaches to the development of scabicidal agents and the improvement of preventive measures in foci of scabies] [Olifer, Veronika Valentinovna. Avtoref. diss…kand.biol.nauk. PMGMU MZ RF]. Moskva. Rossiya.Wendel, K., & Rompalo, A. (2002). Scabies and pediculosis pubis: an update of treatment regimens and general review. Clinical Infectious Diseases, 35(Supplement_2), S146-S151.Ryazancev, I. V. (2004). Sovershenstvovanie lechebno- profilakticheskih meropriyatij pri chesotke v VS RF [Improving treatment and preventive measures for scabies in the Armed Forces of the Russian Federation] [Ryazancev, Ivan Valer’evich. Avtoref. diss…kand.med.nauk. GIUV MO RF]. Moskva. Rossiya.Workowski, K. A., Berman, S. (2010). Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbidity and Mortality Weekly Report, 59(12), 89–90.Sokolova, T. V., & Malyarchuk, A. P. (2009). Therapy of scabies. Klinicheskaya dermatologiya i venerologiya [Clinical Dermatology and Venereology], 6, 64-67.

The authors declare that there are no conflicts of interest present.